Search the Newsreel

Transcript : Align Technology, Inc., Q2 2026 Earnings Call, Jul 29, 2026

This article provides the transcript for Align Technology, Inc.'s Second Quarter 2026 Earnings Call held on July 29, 2026. The company, known for Invisalign, reportedly beat quarterly estimates due to strong dental demand. The earnings call includes a presentation by S&P Capital IQ and …

Align Technology (ALGN) Q2 Earnings and Revenues Top Estimates

Align Technology (ALGN) came out with quarterly earnings of $2.64 per share, beating the Zacks Consensus Estimate of $2.56 per share. This compares to earnings of $2.49 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Align Technology Releases Q2 2026 Financial Results

Align Technology (ALGN) has announced its second-quarter 2026 financial results, with non-GAAP earnings per share of $2.64, surpassing analyst estimates. The company reported revenue of $1.06 billion, matching forecasts and showing a 4.3% increase year-over-year. The Clear Aligner segment drove performance with an 8.2% …

Align Technology adds directors, boosts buyback after Elliott talks

Align Technology Inc. announced it would add three independent directors to its board and increase its share repurchase commitment to between $400 million and $500 million of common stock. These actions follow discussions with Elliott Investment Management, a major investor in the company. Align …

Align Technology to add directors, launch review after deal with Elliott

July 29 (Reuters) - Align Technology will add three new independent directors to its board and launch a review of its operations ‌following talks with activist investor Elliott Investment Management, the company said ‌on Wednesday. Shares of the medical device maker were down 4.5% …

Align Technology Will Appoint 3 Directors After Elliott Talks

Align Technology (ALGN) announced key strategic initiatives, including the appointment of three new independent directors to its Board following discussions with Elliott Investment Management. The company also launched a comprehensive strategic and operating model review to enhance growth and operational effectiveness. Additionally, Align increased …

Align Technology Announces Strategic Initiatives Consistent with Long-term Growth and Shareholder Value Creation Objectives

Board refreshment process to Add Three New Independent Directors with Healthcare, Technology and Operational Expertise Align has engaged a market leading global consulting firm as a strategic advisor to support the Company's next phase of growth by Enhancing Long-Term Commercial Excellence, Margin Expansion, and …

Align Technology (NASDAQ:ALGN) Reports Q2 CY2026 In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations

Align Technology (NASDAQ:ALGN) Reports Q2 CY2026 In Line With Expectations But Quarterly Revenue Guidance Slightly Misses Expectations Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street's revenue expectations in Q2 CY2026, with sales up 4.3% year on year to $1.06 billion. On the other …

Align Technology Announces Second Quarter 2026 Financial Results

Record Q2'26 revenues of $1.06 billion increased 4.3% year-over-year, reflecting 8.2% growth from Clear Aligner revenues and a 10.8% decrease in Systems and Services revenues Record Clear Aligner shipments of 691.8 thousand increased 7.4% year-over-year, led by double-digit international growth and stable North America …

Align Technology earnings up next: Growth momentum in focus By Investing.com

Align Technology (ALGN) is set to report its second-quarter results, with analysts expecting modest year-over-year gains in EPS and revenue. Despite a bullish stance from Wall Street and a growing clear aligners market, some caution exists as EPS and revenue estimates have slightly declined. …

Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About the Investigation of Potential Securities Law Violations

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare …

Align Technology to overhaul board following engagement with Elliott

Align Technology announced it will add three independent directors to its board and launch a comprehensive operational review after discussions with activist investor Elliott Investment Management. The strategic changes aim to improve revenue growth and boost profit margins, and the company also increased its …

Bronstein, Gewirtz & Grossman, LLC Encourages Alignment Healthcare, Inc. (ALHC) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential securities claims on behalf of purchasers of Alignment Healthcare, Inc. (ALHC). This investigation follows allegations from a former executive of "accounting irregularities" and the artificial inflation of financial results, including "Adjusted EBITDA," which led to a …

ALIGN TECHNOLOGY ($ALGN) Releases Q2 2026 Earnings

This article first appeared on GuruFocus. Revenue: Record Q2 2026 revenue of $1.06 billion, up 4.3% year-over-year. Clear Aligner Revenue: $870.9 million, up 8.2% year-over-year. Clear Aligner Volume: Record 692,000 cases, up 7.4% year-over-year. Clear Aligner ASP: $1,260 per case, up 0.8% year-over-year. Systems …

Align Technology (NASDAQ:ALGN) Issues Earnings Results

Align Technology (ALGN) Earnings Date and Reports 2026

Alignment Healthcare (ALHC) Reports Earnings Tomorrow: What To Expect

Alignment Healthcare (ALHC) is set to announce its earnings this Thursday afternoon. The company exceeded revenue expectations last quarter, reporting $1.24 billion, a 33.3% year-on-year increase, and analysts are projecting a 29% revenue growth for the upcoming quarter. Despite a positive sentiment in the …

Alignment Healthcare Inc (ALHC) Cash Flow

This article provides a detailed cash flow statement for Alignment Healthcare Inc (ALHC), presenting quarterly and annual figures for operating, investing, and financing activities. It includes key financial metrics such as net income from continuing operations, capital expenditures, and free cash flow, along with …

Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz has initiated an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) regarding potential federal securities law violations. This follows a whistleblower lawsuit filed by a former executive, alleging financial manipulation to inflate the company's stock price and executive …

ALHC INVESTOR ALERT: HBSS Launches Investigation into

Hagens Berman Sobol Shapiro LLP has launched an investigation into Alignment Healthcare, Inc. (ALHC) following whistleblower allegations of financial manipulation. A former executive claims the company misclassified operating expenses as capital expenditures to inflate adjusted EBITDA for 2024 and 2025, artificially boosting its stock …

ALHC INVESTOR ALERT: HBSS Launches Investigation into Alignment Healthcare, Inc. (ALHC) Following Whistleblower Allegations of Financial Manipulation

SAN FRANCISCO, July 28, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman (HBSS) is investigating potential violations of U.S. securities laws by Alignment Healthcare, Inc. (NASDAQ: ALHC) following reports of a whistleblower lawsuit alleging systemic financial manipulation. SUBMIT YOUR ALHC INVESTMENT LOSSES …

Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations after a whistleblower alleged accounting irregularities that artificially inflated the company's financial results. This follows news on July 8, 2026, where the stock price fell 16.7% after allegations …

Analysts Estimate Alight, Inc. (ALIT) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on lower revenues when Alight, Inc. (ALIT) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term …

How Align Technology Inc. (ALGN) Affects Rotational Strategy Timing

This article analyzes Align Technology Inc. (ALGN) using AI models to determine its impact on rotational strategy timing. It highlights weak near and mid-term sentiment but a strong long-term outlook for the stock, presenting specific entry, target, and stop-loss levels for different trading strategies. …

Align Technology (ALGN) Reports Q2: Everything You Need To Know Ahead Of Earnings

Align Technology (ALGN) is set to announce its Q2 earnings, with analysts expecting a 3.8% year-on-year revenue growth. The company previously exceeded revenue expectations, reporting $1.04 billion, a 6.2% increase from the prior year. Despite recent analyst reconfirmations, Align Technology has missed revenue estimates …

Align Technology Inc (ALGN) Financial Health: Profitability & Balance Sheet Analysis

Align Technology Inc (ALGN) has a robust financial status with a current financial score of 8.82, ranking 24th in the Healthcare Equipment & Supplies industry. The company reported a 6.21% year-over-year revenue increase to $1.04 billion and a 20.96% year-over-year net profit increase. Despite …

Does Align’s New AI-Powered Workflow Suite Reshape The Bull Case For Align Technology (ALGN)?

Align Technology has introduced new AI-powered tools and workflow enhancements across its Align Digital Platform, integrating features like AI X-ray Insights and 3D facial simulations. These additions aim to deepen Align's integration into dental practices and potentially reinforce clinician reliance on its ecosystem. The …

Align Technology Inc (ALGN) Institutional Confidence

Align Technology Inc (ALGN) has an institutional shareholding score of 10.00, placing it first in its industry. The latest institutional shareholding proportion is 99.80%, indicating a slight quarter-over-quarter decrease. Ruane Cunniff is the largest institutional shareholder, holding 1.27 million shares.

BlackRock (ALIT holder) discloses 14.7M Alight Inc. Class A shares on 13G/A

BlackRock, Inc. has filed an amended Schedule 13G/A, reporting beneficial ownership of 14,741,561 Class A shares of Alight Inc. This holding represents 2.8% of the outstanding Class A shares, with BlackRock exercising sole voting and dispositive power. The filing notes that while various underlying …

BlackRock (ALHC) discloses 18.7M Alignment Healthcare shares with sole voting power

BlackRock, Inc. has filed a Schedule 13G/A, disclosing beneficial ownership of 18,719,986 shares of Alignment Healthcare, Inc. (ALHC) common stock, which represents a 9.1% stake. BlackRock holds sole voting power over 18,431,099 shares and sole dispositive power over all 18,719,986 shares. No single underlying …

ALGS|Aligos Therapeutics Inc|Price:4.075|Chg%:-0.005

This article provides a comprehensive stock analysis of Aligos Therapeutics Inc (ALGS), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation within the Biotechnology & Medical Research industry. It notes strong institutional ownership and a recent "Buy" rating from analysts with a …

ALHC INVESTOR ALERT: Holzer & Holzer, LLC Announces Investigation of Alignment Healthcare, Inc.

Holzer & Holzer, LLC has launched an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) to determine if the company violated federal securities laws. This investigation follows a lawsuit filed by a former executive alleging that Alignment materially misclassified millions in operating expenses as capital …

Aligos Therapeutics Inc (ALGS) Cash Flow

This article provides an in-depth look at Aligos Therapeutics Inc's (ALGS) cash flow statements, including operating, investing, and financing activities, across quarterly and annual periods. It details various components like net income, capital expenditures, and changes in working capital. The piece also includes an …

Aligos Therapeutics Inc (ALGS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Aligos Therapeutics Inc (ALGS). However, it states that relevant data regarding business segments, regional revenue, and profit contribution for ALGS have not yet been disclosed by the company. The page also displays current stock information …

ALGS|Aligos Therapeutics Inc|Price:4.080|

Aligos Therapeutics Inc. is a clinical-stage biotechnology company focused on developing therapies for liver diseases and viral infections, including chronic hepatitis B (HBV), MASH, and coronaviruses. The company's pipeline features lead candidates like ALG-000184 for HBV, ALG-055009 for MASH, and ALG-097558 for coronavirus infections. …

Alignment Healthcare (ALHC) Slides as Investors Digest Index Addition and Leadership Shake-up

Alignment Healthcare (ALHC) experienced a stock decline following news of its inclusion in the S&P SmallCap 600 index and a leadership change. The company announced that CEO John Kao will transition to Executive Chairman, with Ken Goulet taking over as CEO. Investors are likely …